NL-OMON29171尚未招募不适用
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gait.
Roessingh Research and DevelopmentRoessinghsbleekweg 337577 AH Enschede0 个研究点目标入组 26 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 26
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age over 18 years;
- •2. 6 months post stroke;
排除标准
- •1. Presence of other constraints in joints who impede walking;
- •2. Neurological problems not causes by a Cerebro Vascular Accident;
研究者
相似试验
已完成
不适用
Effect of botulinum toxin A injections and specific intensive rehabilitation therapy in children with hemiparetic cerebral palsy on upper limb functions and skillsCerebral palsyISRCTN69541857Ipsen Biopharm Ltd (UK)60
进行中（未招募）
不适用
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.EUCTR2009-018226-29-NL26
已完成
3 期
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166NL-OMON39359Revalidatiecentrum Het Roessingh26
已完成
2 期
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42IRCT20190129042540N1Rafsanjan University of Medical Sciences50
进行中（未招募）
不适用
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)Study design: a factorial design with four study groups in which btA alone, intensive rehabilitation therapy aimed at improving bimanual skills alone, a combination of these two and continuing the regular therapy program will be compared to each other.Study population: children with CP, spastic hemiparesis, aged 2.5 – 12 years.EUCTR2006-002175-40-NL60